通道酶TRPM7调控PKC/NOX4/ROS信号在类风湿关节炎关节软骨细胞铁死亡中的作用及其机制
批准号:
81902182
项目类别:
青年科学基金项目
资助金额:
20.0 万元
负责人:
周仁鹏
依托单位:
学科分类:
H0602.运动系统免疫相关疾病
结题年份:
2022
批准年份:
2019
项目状态:
已结题
项目参与者:
--
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
瞬时受体电位通道7(TRPM7)属于TRPM亚家族中的一员,其激活可介导Ca2+等内流,参与氧化应激、炎症等病理反应过程。铁死亡是2012年发现的一种新型细胞死亡方式,与神经元损伤等病理过程有关。我们前期研究证实在类风湿关节炎(RA)患者和佐剂型关节炎(AA)大鼠关节软骨细胞中存在铁死亡,且阻断TRPM7对其有保护作用。在此基础上试图(1)使用TRPM7特异性阻断剂、激动剂、过表达或shRNA质粒,分析其对Erastin诱导的AA大鼠关节软骨细胞铁死亡的调控作用。(2)运用全细胞膜片钳、激光共聚焦显微镜等,分析Ca2+及其下游PKC/NOX4/ROS信号在TRPM7调控软骨细胞铁死亡中的作用。(3)体内给予TRPM7与铁死亡特异性抑制剂,分析TRPM7、铁死亡与RA软骨细胞损伤之间的内在联系。初步阐明TRPM7在AA大鼠关节软骨细胞铁死亡中的作用及可能机制,为RA的治疗提供新的靶点。
英文摘要
Transient receptor potential melastatin 7, TRPM7, is a member of the TRPM subfamily and has a dual function of cation channel and kinase activity. TRPM7 activation can lead to extracellular Ca2+ and other ion influx, and thus and participates in pathological processes such as oxidative stress and inflammation. Ferroptosis is a new type of cell death that was discovered in 2012 and is different from apoptosis and necrosis. Ferroptosis is related to pathological processes such as tumor suppression and neuronal damage. Our previous study have been confirmed that ferroptosis existed in articular chondrocytes of rheumatoid arthritis (RA) patients and adjuvant arthritis (AA) rats, and blocking TRPM7 has a protective effect on chondrocyte ferroptosis. On this basis, we attempted to use TRPM7 specific blockers, agonists, overexpression or shRNA plasmids to analyze the effect of TRPM7 on Erastin-induced ferroptosis in articular chondrocytes of AA rats in vitro. Moreover, TRPM7 currents are recorded with whole-cell patch-clamp and fast-perfusion techniques, and intracellular calcium ([Ca2+]i) in chondrocytes are recorded by using the laser scanning confocal microscopy. We analyzed the role of TRPM7-mediated Ca2+ overload and its downstream PKC/NOX4/ROS signaling pathway in chondrocyte ferroptosis. Furthermore, the TRPM7-specific blocker and the ferroptosis-specific inhibitor Ferrostatin-1 were administered in vivo to analyze the relationship between TRPM7, ferroptosis and RA chondrocyte injury. In this research proposal, we try to preliminarily clarify the protective effect and mechanism of blocking TRPM7 on ferroptosis of articular chondrocytes of rats with adjuvant arthritis. Therefore, we hypothesized that inhibiting TRPM7 would provide protection for the articular cartilage in adjuvant arthritis (AA) rats via reducing chondrocyte ferroptosis, and can be used as potent therapeutic targets for the treatment of cartilage destruction diseases including RA in future.
类风湿性关节炎(RA)是一种系统性的自身免疫性疾病,是造成人群丧失劳动力和致残的主要病因之一。关节软骨及骨组织破坏是导致RA患者残疾的直接原因,而关节软骨细胞死亡又是诱发软骨破坏的主要始动因素。铁死亡(Ferroptosis)是一种新型的铁依赖性非凋亡性细胞死亡方式,目前尚不清楚铁死亡在RA关节软骨破坏中的作用和确切的调控机制。本项目以RA患者组织样本和RA动物模型为研究对象,考察铁死亡在RA软骨细胞死亡和软骨组织破坏中作用,以瞬时电位受体通道7 (TRPM7)为靶点,探究通道酶TRPM7对佐剂型关节炎(AA)大鼠关节软骨细胞铁死亡中的调控作用及分子机制。在本研究中,首次证明RA患者和AA大鼠的关节软骨细胞发生铁死亡,发现TRPM7是RA关节软骨细胞铁死亡和RA进展的关键调控靶点。发现TRPM7在RA患者和AA大鼠关节软骨组织,以及铁死亡诱导剂Erastin处理的关节软骨细胞中表达均明显升高。进一步研究显示,TRPM7阻断或表达沉默后可以抑制Erastin诱导的软骨细胞铁死亡,表现为逆转Erastin诱导的铁死亡标志物GPX4、SLC7A11和ACSL4表达变化、线粒体形态变化以及生化指标的改变。此外,我们发现TRPM7通过通道活性介导胞内Ca2+水平升高促进软骨细胞的铁死亡。机制研究发现,TRPM7的基因敲低和药理抑制均可通过PKCα-NOX4轴减弱软骨细胞铁死亡和RA关节软骨破坏。分子对接、分子动力学模拟和丙氨酸扫描揭示NOX4蛋白R231位氨基酸残基可能是NOX4-PKCα相互作用的关键结合位点。体内实验进一步验证,TRPM7沉默或阻断可抑制软骨细胞铁死亡并减轻AA大鼠关节软骨破坏。本项目揭示了通道酶TRPM7通过PKCα-NOX4轴调控软骨细胞铁死亡和RA关节软骨破坏的作用机制,表明靶向抑制TRPM7介导的关节软骨细胞铁死亡可为RA的防治提供新策略。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1111/imm.13420
发表时间:2022
期刊:Immunology
影响因子:--
作者:Liang Hong-Yu;Chen Yong;Wei Xin;Ma Gang-Gang;Ding Jie;Lu Chao;Zhou Ren-Peng;Hu Wei
通讯作者:Hu Wei
TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCα-NOX4 axis.
TRPM7 通道抑制通过抑制 PKCα-NOX4 轴来减轻类风湿性关节炎关节软骨细胞铁死亡
DOI:10.1016/j.redox.2022.102411
发表时间:2022-09
期刊:REDOX BIOLOGY
影响因子:11.4
作者:Zhou, Renpeng;Chen, Yong;Li, Shufang;Wei, Xin;Hu, Weirong;Tang, Suan;Ding, Jie;Fu, Wanjin;Zhang, Hailin;Chen, Fan;Hao, Wenjuan;Lin, Yi;Zhu, Rendi;Wang, Ke;Dong, Lei;Zhao, Yingjie;Feng, Xiaowen;Chen, Feihu;Ding, Changhai;Hu, Wei
通讯作者:Hu, Wei
Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis.
百先锋汤调节TNF-PI3K-Akt-NF-κB通路治疗类风湿关节炎的全身药理学验证
DOI:10.1016/j.bioorg.2021.105519
发表时间:2021-11
期刊:Bioorganic Chemistry
影响因子:5.1
作者:Wei Xin;Zhou Renpeng;Chen Yong;Ma Ganggang;Yang Yang;Lu Chao;Xu Weiping;Hu Wei
通讯作者:Hu Wei
Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis.
KCa3.1 在免疫细胞功能中的调节作用及其与类风湿性关节炎的新兴关联
DOI:10.3389/fimmu.2022.997621
发表时间:2022
期刊:FRONTIERS IN IMMUNOLOGY
影响因子:7.3
作者:Lin, Yi;Zhao, Ying-Jie;Zhang, Hai-Lin;Hao, Wen-Juan;Zhu, Ren-Di;Wang, Yan;Hu, Wei;Zhou, Ren-Peng
通讯作者:Zhou, Ren-Peng
Nerve growth factor promotes ASIC1a expression via the NF-κB pathway and enhances acid-induced chondrocyte apoptosis
神经生长因子通过 NF-κB 途径促进 ASIC1a 表达并增强酸诱导的软骨细胞凋亡
DOI:10.1016/j.intimp.2020.106340
发表时间:2020
期刊:International Immunopharmacology
影响因子:5.6
作者:Xin Wei;Cheng Sun;Ren-Peng Zhou;Gang-Gang Ma;Yang Yang;Chao Lu;Wei Hu
通讯作者:Wei Hu
KCa3.1介导线粒体质量控制在TRPM7调控类风湿关节炎关节软骨细胞铁死亡中的作用机制研究
- 批准号:--
- 项目类别:面上项目
- 资助金额:52万元
- 批准年份:2022
- 负责人:周仁鹏
- 依托单位:
国内基金
海外基金















{{item.name}}会员


